Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Univ. Spin-Off Reports Cancer Immunotherapy Advance

A highly targeted synthetic antibody, developed by a university spin-off enterprise, was shown to destroy human breast cancer cells grafted in lab mice. . . . → Read More: Univ. Spin-Off Reports Cancer Immunotherapy Advance

Online Game Harnessed to Combat Foodborne Toxins

A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops. . . . → Read More: Online Game Harnessed to Combat Foodborne Toxins

Roche, Biotech to Discover New Antibiotics

A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics. . . . → Read More: Roche, Biotech to Discover New Antibiotics

Flashback: Drug Pricing Reform Even Big Pharma Might Like

Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October.

(TBIT/Pixabay)

2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription . . . → Read More: Flashback: Drug Pricing Reform Even Big Pharma Might Like

Gas-Jet Printing Process Developed for Medications

A team of material scientists and biomedical engineers designed techniques for producing pharmaceuticals on demand by printing drugs as thin films. . . . → Read More: Gas-Jet Printing Process Developed for Medications

IBM, UC San Diego Partner on Healthy Aging

IBM and University of California at San Diego are launching a joint research project to gain new insights with artificial intelligence on cognitive and gut microbe health in older people. . . . → Read More: IBM, UC San Diego Partner on Healthy Aging

Biotech Licenses Gene Editing for Autoimmune Disorders

A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases. . . . → Read More: Biotech Licenses Gene Editing for Autoimmune Disorders

Trial Comparing 2-D, 3-D Mammogram Outcomes

A large-scale clinical trial is underway comparing the effectiveness of two-dimensional and three-dimensional mammograms in screening for breast cancer. . . . → Read More: Trial Comparing 2-D, 3-D Mammogram Outcomes

Algorithms ID Factors in Parkinson’s Progression

Data from two clinical trials analyzed with machine learning algorithms identify factors that predict the decline of motor functions in individuals with Parkinson’s disease. . . . → Read More: Algorithms ID Factors in Parkinson’s Progression

Heart Scans Devised for Biometric Identification

A computer science team designed a method for reading heart muscle contractions that uniquely identifies individuals for computer log-in and secure entry. . . . → Read More: Heart Scans Devised for Biometric Identification